Congenital heart anomalies encompass structural abnormalities in the heart present at birth, arising during the intricate process of fetal heart development. Though the precise causes remain elusive, a combination of genetic predisposition, environmental factors, and specific maternal health conditions may contribute to their manifestation. These anomalies impact the heart's structure, involving chambers, valves, or blood vessels, thereby disrupting the normal blood flow and giving rise to diverse complications. Examples of congenital heart anomalies include but are not limited to atrial septal defects, ventricular septal defects, and tetralogy of Fallot. The severity of congenital heart anomalies varies, with some cases presenting as minor issues that may not necessitate immediate intervention, while others may demand surgical correction. Ongoing advancements in medical technology and surgical procedures have markedly enhanced the outlook for individuals affected by congenital heart anomalies. This progress facilitates early detection, timely intervention, and improved long-term outcomes.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation